- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00577343
Hospital Acquired and Community Acquired MRSA in GI Lab
February 29, 2016 updated by: Indiana University
Hospital Acquired and Community Acquired Methicillin Resistant Staph Aureus in the Outpatient Gastrointestinal Lab: A Prospective Study of Prevalence
Hospital acquired and community acquired methicillin resistant staph aureus (MRSA) has become an important health issue for in recent years.
Up to two thirds of patients that are hospitalized may be colonized with MRSA.
The prevalence in the community is also on the rise and affects the young and healthy.
It is unclear what the true prevalence of MRSA is in our own hospital and outpatient setting.
This information would be relevant to how healthcare staff adhere to contact and universal precautions.
: The purpose of this study is to determine the prevalence of MRSA in patients that have gastrointestinal endoscopy and endoscopic ultrasound.
Study Overview
Status
Withdrawn
Conditions
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
Indianapolis, Indiana, United States, 46202
- Clarian/Indiana University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
gastrointestinal lab of oupatient and inpatients
Description
Inclusion Criteria:
- No evidence of dementia or altered mental status that would prohibit the giving and understanding of informed consent, and no evidence of psychiatric risk that would preclude adequate compliance with this protocol.
Subjects must provide signed written informed consent.
Exclusion Criteria:
- Inability to provide written informed consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The objective of this prospective study is to identify the prevalence of MRSA in patients that use the Indiana University GI lab.
Time Frame: less than one year
|
less than one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2009
Primary Completion (Anticipated)
December 1, 2010
Study Completion (Anticipated)
December 1, 2010
Study Registration Dates
First Submitted
December 19, 2007
First Submitted That Met QC Criteria
December 19, 2007
First Posted (Estimate)
December 20, 2007
Study Record Updates
Last Update Posted (Estimate)
March 1, 2016
Last Update Submitted That Met QC Criteria
February 29, 2016
Last Verified
February 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- 0705-31
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hospital Acquired MRSA
-
PfizerUniversity of Louisville; Summa Health System; Sparrow Health System; Jackson Health... and other collaboratorsCompletedHospital-Acquired Pneumonia | Methicillin-Resistant Staphylococcus Aureus (MRSA)
-
Hvidovre University HospitalRecruiting
-
National University of SingaporeSaglik Bilimleri UniversitesiRecruitingHospital-acquired InfectionsCambodia
-
Assaf-Harofeh Medical CenterGama Healthcare Ltd.CompletedHospital Acquired InfectionIsrael
-
Peking University Third HospitalCompletedHospital Acquired InfectionChina
-
University Hospital, Basel, SwitzerlandRecruiting
-
Hong Kong University of Science and TechnologyQueen Elizabeth Hospital, Hong Kong; Kowloon Hospital, Hong Kong; Innovation...CompletedHospital Acquired InfectionsHong Kong
-
Shanghai Zhongshan HospitalRecruitingSurgery | Intensive Care Unit | Hospital-Acquired Infection | ChlorhexidineChina
-
Shanghai Zhongshan HospitalNot yet recruitingAnalgesia | Hospital-acquired Infections
-
National Institute of Allergy and Infectious Diseases...Completed